Related Experiment Video
Updated: Sep 27, 2026
Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
Comparison of MR and PET imaging for the evaluation of liver metastases
Ming Yang1, Diego R Martin, Nevzat Karabulut
1Department of Radiology, West Virginia University, School of Medicine, Morgantown, West Virginia 26505-9235, USA.
Purpose:
To compare the accuracy of fluoro-18-deoxyglucose positron emission tomography (FDG-PET) and dynamic-enhanced magnetic resonance imaging (MRI) scans in the diagnosis of liver metastatic lesions from colon and other sources.
Materials And Methods:
Thirty consecutive patients with known or suspected metastatic lesions were scanned by both MRI and PET. Histopathology and/or clinical outcome, including cross-sectional imaging follow up, were used as a gold standard.
Results:
Of 30 patients, 16 were positive by pathology and/or clinical outcome and 14 were negative for liver metastases. The sensitivity, specificity, and positive and negative predictive values on MRI were 85.7%, 100%, 100%, and 89%, respectively, compared to 71%, 93.7%, 90.9%, and 79% on FDG-PET. The difference between the two methods was not significant (X(2) = 0.2, P > 0.05).
Conclusion:
Our study showed no significant difference in detection of liver metastases using MRI or FDG-PET. However, MRI has advantages in spatial resolution and lesion characterization.
Insights
Magnetic resonance imaging (MRI) and fluoro-18-deoxyglucose positron emission tomography (FDG-PET) show similar accuracy for detecting liver metastases. MRI offers better spatial resolution and lesion characterization for diagnosing metastatic liver lesions.
Area of Science:
- Oncology
- Radiology
- Diagnostic Imaging
Background:
- Accurate detection of liver metastases is crucial for colon cancer staging and treatment planning.
- Both MRI and FDG-PET are utilized for diagnosing liver lesions, but their comparative accuracy requires further investigation.
Purpose of the Study:
- To compare the diagnostic accuracy of dynamic-enhanced MRI and FDG-PET in identifying liver metastatic lesions.
- To evaluate the effectiveness of these imaging modalities for various primary cancer sources.
Main Methods:
- A prospective study involving 30 patients with known or suspected liver metastases.
- Both MRI and FDG-PET scans were performed on all participants.
- Histopathology and clinical outcomes served as the gold standard for diagnosis.
Main Results:
- MRI demonstrated a sensitivity of 85.7% and specificity of 100%, while FDG-PET showed 71% sensitivity and 93.7% specificity.
- Positive predictive values were 100% for MRI and 90.9% for FDG-PET; negative predictive values were 89% for MRI and 79% for FDG-PET.
- Statistical analysis revealed no significant difference in the detection rates between MRI and FDG-PET (X(2) = 0.2, P > 0.05).
Conclusions:
- Neither MRI nor FDG-PET showed a statistically significant difference in detecting liver metastases.
- MRI offers superior spatial resolution and lesion characterization capabilities compared to FDG-PET.
- Both modalities are valuable tools, with MRI potentially providing more detailed information for clinical decision-making.
More Related Videos
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
01:27Imaging Studies IV: Magnetic Resonance Imaging
01:29Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...